Equity Brief: Ratings Changes for December 18th: HERO, HFC, HIBB, HMA, HPQ, HRZN, IDIX, IGT
(Thomson Reuters ONE) -
A number of stocks were upgraded and downgraded by equities research analysts
today, as reported by Analyst Ratings Network (http://bit.ly/equitybriefdaily)
and Equity Brief:
Deutsche Bank reiterated its buy rating on shares of Hercules Offshore, Inc.
(HERO). They have a $5.00 price target on the stock, down previously from $8.00.
Oppenheimer raised its price target on shares of HollyFrontier Corp (HFC) from
$46.00 to $55.00. They have an outperform rating on the stock.
Feltl & Co. upgraded shares of Hibbett Sports, Inc. (HIBB) from a hold rating to
a buy rating. Feltl & Co. now has a $63.00 price target on the stock.
Robert W. Baird reiterated its neutral rating on shares of Health Management
Associates (HMA). They have a $10.00 price target on the stock, up previously
from $9.00.
JPMorgan Chase initiated coverage on shares of Health Management Associates
(HMA). They issued a neutral rating on the stock.
RBC Capital reiterated its sector perform rating on shares of Hewlett-Packard
(HPQ). They have a $18.00 price target on the stock, up previously from $14.00.
Topeka Capital downgraded shares of Hewlett-Packard (HPQ) from a hold rating to
a sell rating. Their analysts now have a $11.50 price target on the stock. They
wrote, "In less than a month, HP's stock has rallied 31% from the November 20th
low to yesterday's intra-day high on what we believe is a combination of hope
that a major shake up at HP is around the corner and short covering activity.
Given the secular portfolio challenges we expect HP to face in the foreseeable
future, combined with a soft spending environment, we believe investors should
take advantage of this early holiday gift and take profits in the stock."
Wells Fargo & Co. upgraded shares of Horizon Technology Finance (HRZN) from a
market perform rating to an outperform rating.
Deutsche Bank reiterated its rating on shares of Idenix Pharmaceuticals, Inc.
(IDIX). They have a $7.00 price target on the stock.
Deutsche Bank reiterated its buy rating on shares of International Game
Technology (IGT). They have a $16.00 price target on the stock, down previously
from $19.00.
Robert W. Baird reiterated its neutral rating on shares of Illumina, Inc.
(ILMN). They have a $54.00 price target on the stock.
Stay on top of analysts' coverage with Analyst Ratings Network's free daily
email newsletter that provides a concise list of analysts' upgrades, downgrades
and initiations. Register at http://bit.ly/equitybriefdaily
Content and Media Contact: newseditor(at)equitybrief.net
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Equity Brief via Thomson Reuters ONE
[HUG#1666081]
Datum: 18.12.2012 - 16:26 Uhr
Sprache: Deutsch
News-ID 214024
Anzahl Zeichen: 3397
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 169 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Equity Brief: Ratings Changes for December 18th: HERO, HFC, HIBB, HMA, HPQ, HRZN, IDIX, IGT"
steht unter der journalistisch-redaktionellen Verantwortung von
Equity Brief (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
